Log in to save to my catalogue

Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling

Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4362254

Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling

About this item

Full title

Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2015-03, Vol.125 (3), p.1129-1146

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Recombinant adenoviral vectors (rAds) are lead vaccine candidates for protection against a variety of pathogens, including Ebola, HIV, tuberculosis, and malaria, due to their ability to potently induce T cell immunity in humans. However, the ability to induce protective cellular immunity varies among rAds. Here, we assessed the mechanisms that cont...

Alternative Titles

Full title

Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4362254

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4362254

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI78280

How to access this item